FERRANTE, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 729
EU - Europa 593
AS - Asia 384
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.707
Nazione #
US - Stati Uniti d'America 729
CN - Cina 141
UA - Ucraina 109
IE - Irlanda 106
TR - Turchia 105
SG - Singapore 98
SE - Svezia 89
GB - Regno Unito 86
FR - Francia 63
DE - Germania 49
IT - Italia 45
IN - India 34
FI - Finlandia 28
RU - Federazione Russa 14
VN - Vietnam 3
CZ - Repubblica Ceca 2
A2 - ???statistics.table.value.countryCode.A2??? 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
PL - Polonia 1
Totale 1.707
Città #
Chandler 159
Jacksonville 126
Dublin 106
Singapore 89
Southend 84
Dearborn 62
Ashburn 55
Izmir 47
Princeton 42
Nanjing 35
Santa Clara 29
Beijing 28
Wilmington 26
Cambridge 21
Altamura 15
Munich 14
Washington 14
Nanchang 13
Ann Arbor 9
Chieti 8
Hebei 8
Kunming 8
Boardman 7
Grevenbroich 7
Helsinki 7
Shenyang 7
Woodbridge 6
Seattle 5
Falls Church 4
Jiaxing 4
Jinan 4
Los Angeles 4
San Mateo 4
Tianjin 4
Anzola Dell'emilia 3
Augusta 3
Changsha 3
Dong Ket 3
Lanzhou 3
Ningbo 3
Norwalk 3
Roseto degli Abruzzi 3
Chaoyang 2
Fuzhou 2
New York 2
Bellante 1
Brno 1
Catania 1
Chongqing 1
Greifswald 1
Hangzhou 1
Kraków 1
Louisville 1
Melita 1
Moscow 1
Mountain View 1
Newcastle Upon Tyne 1
Olomouc 1
Pescara 1
Phnom Penh 1
San Giacomo degli Schiavoni 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Torino 1
Vientiane 1
West Chester 1
Zhengzhou 1
Ürümqi 1
Totale 1.115
Nome #
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 115
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 102
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 100
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 100
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 91
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 90
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 90
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 88
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 88
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 87
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 84
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 84
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 81
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 80
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 79
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 71
CD40 ligand and MCP-1 levels as predictors of cardiovascular events in lacunar and non-lacunar strokes. 70
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 69
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 67
Endogenous secretory rage in obese women: association with oxidative stress and platelet activation. Proc. 112° Congr. Naz. Soc It. Med. Interna, Roma, ottobre 2011, Int Emerg Med 6(S2): S186, 2011 61
CD40 ligand and MCP-1 as predictors of cardiovascular events in lacunar and non-lacunar strokes. 59
Totale 1.756
Categoria #
all - tutte 6.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020236 0 0 0 0 34 36 50 43 4 40 28 1
2020/2021110 22 0 23 0 4 21 0 1 15 20 1 3
2021/202294 0 4 0 26 9 3 1 6 11 3 10 21
2022/2023364 21 56 29 35 47 66 17 23 53 5 6 6
2023/2024192 14 6 19 7 19 61 49 6 0 1 0 10
2024/2025212 18 103 75 10 6 0 0 0 0 0 0 0
Totale 1.756